TY - JOUR
T1 - Engineering Mesoscopic 3D Tumor Models with a Self-Organizing Vascularized Matrix
AU - De Lorenzi, Federica
AU - Hansen, Nadja
AU - Theek, Benjamin
AU - Daware, Rasika
AU - Motta, Alessandro
AU - Breuel, Saskia
AU - Nasehi, Ramin
AU - Baumeister, Julian
AU - Schöneberg, Jan
AU - Stojanović, Natalija
AU - von Stillfried, Saskia
AU - Vogt, Michael
AU - Müller-Newen, Gerhard
AU - Maurer, Jochen
AU - Sofias, Alexandros Marios
AU - Lammers, Twan
AU - Fischer, Horst
AU - Kiessling, Fabian
N1 - Publisher Copyright:
© 2023 The Authors. Advanced Materials published by Wiley-VCH GmbH.
PY - 2024/2/1
Y1 - 2024/2/1
N2 - Advanced in vitro systems such as multicellular spheroids and lab-on-a-chip devices have been developed, but often fall short in reproducing the tissue scale and self-organization of human diseases. A bioprinted artificial tumor model is introduced with endothelial and stromal cells self-organizing into perfusable and functional vascular structures. This model uses 3D hydrogel matrices to embed multicellular tumor spheroids, allowing them to grow to mesoscopic scales and to interact with endothelial cells. It is shown that angiogenic multicellular tumor spheroids promote the growth of a vascular network, which in turn further enhances the growth of cocultivated tumor spheroids. The self-developed vascular structure infiltrates the tumor spheroids, forms functional connections with the bioprinted endothelium, and can be perfused by erythrocytes and polystyrene microspheres. Moreover, cancer cells migrate spontaneously from the tumor spheroid through the self-assembled vascular network into the fluid flow. Additionally, tumor type specific characteristics of desmoplasia, angiogenesis, and metastatic propensity are preserved between patient-derived samples and tumors derived from this same material growing in the bioreactors. Overall, this modular approach opens up new avenues for studying tumor pathophysiology and cellular interactions in vitro, providing a platform for advanced drug testing while reducing the need for in vivo experimentation.
AB - Advanced in vitro systems such as multicellular spheroids and lab-on-a-chip devices have been developed, but often fall short in reproducing the tissue scale and self-organization of human diseases. A bioprinted artificial tumor model is introduced with endothelial and stromal cells self-organizing into perfusable and functional vascular structures. This model uses 3D hydrogel matrices to embed multicellular tumor spheroids, allowing them to grow to mesoscopic scales and to interact with endothelial cells. It is shown that angiogenic multicellular tumor spheroids promote the growth of a vascular network, which in turn further enhances the growth of cocultivated tumor spheroids. The self-developed vascular structure infiltrates the tumor spheroids, forms functional connections with the bioprinted endothelium, and can be perfused by erythrocytes and polystyrene microspheres. Moreover, cancer cells migrate spontaneously from the tumor spheroid through the self-assembled vascular network into the fluid flow. Additionally, tumor type specific characteristics of desmoplasia, angiogenesis, and metastatic propensity are preserved between patient-derived samples and tumors derived from this same material growing in the bioreactors. Overall, this modular approach opens up new avenues for studying tumor pathophysiology and cellular interactions in vitro, providing a platform for advanced drug testing while reducing the need for in vivo experimentation.
KW - 3D bioprinting
KW - 3D multicellular tumor spheroid
KW - bioengineering
KW - hydrogels
KW - metastasis
UR - https://www.scopus.com/pages/publications/85176086103
U2 - 10.1002/adma.202303196
DO - 10.1002/adma.202303196
M3 - Article
AN - SCOPUS:85176086103
SN - 0935-9648
VL - 36
JO - Advanced Materials
JF - Advanced Materials
IS - 5
M1 - 2303196
ER -